Illustrative image – not actual.Vivimed Labs has acquired a drug manufacturing facility of Actavis Pharma Manufacturing for a total consideration of Rs 122 crore.
The Hyderabad-based company has taken possession of the Tamil Nadu-based solid oral dosage facility in Alathur, Tamil Nadu.
The unit has been acquired from Actavis Pharma Manufacturing's parent company, Actavis Holding Asia BV. The acquisition will be financed through an optimal combination of internal accruals and debt.
The manufacturing plant has the capacity to produce 1.2 billion solid oral dosages per annum.
Along with this, the company has also acquired two commercially valuable and marketable ANDAs (Abbreviated New Drug Applications) which will allow the company to generate additional revenues.
